ASCLETIS-B: ANNUAL RESULTS OF ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
ASCLETIS-B: VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSTER PRESENTATION OF PHASE II STUDY FINAL RESULTS OF FASN INHIBITOR ASC40 FOR TREATMENT OF ACNE AT 2024 AAD ANNUAL MEETING
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
ASCLETIS-B: NOTICE OF BOARD MEETING
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
ASCLETIS-B: Next Day Disclosure Return
ASCLETIS-B: Next Day Disclosure Return
No Data